a sixty two billion euro tile with agriculture call for monsanto weren't enough twenty seventeen's consumer drug sales were stagnant. system and consumer. we're not satisfied with the development of consumer health. on the one hand competitive forces in the usa require extra investment in our brands. and then in twenty seven teens the unusual situation in china where several over the counter drugs became prescription only product which you could do. and. by as problems are stacking up it's now willing to sell more parts of its business that's to convince authorities to wade through the purchase of monsanto the u.s. food and drug administration is threatening to take buy our products off the shelves of a quality control issues and breck's it could force pharma firms to do the splits